Inhibrx Biosciences IncNASDAQ:INBX
- LAST PRICE12.8700
- TODAY'S CHANGE (%)-0.5700 (-4.2411%)
- Bid / Lots12.7400/ 1
- Ask / Lots20.8800/ 2
- Open / Previous Close13.2300 / 13.4400
- Day Range
- 52 Week Range
- Volume221,401
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INBX |
|---|---|---|
| 09:32 ET | 679 | 13.14 |
| 09:34 ET | 4300 | 13.07 |
| 09:36 ET | 100 | 13.87 |
| 09:38 ET | 100 | 13.55 |
| 09:39 ET | 1500 | 13.35 |
| 09:41 ET | 100 | 13.23 |
| 09:43 ET | 399 | 13.23 |
| 09:45 ET | 4710 | 12.97 |
| 09:48 ET | 100 | 12.98 |
| 09:52 ET | 100 | 12.97 |
| 09:54 ET | 100 | 12.88 |
| 09:56 ET | 100 | 12.92 |
| 09:57 ET | 100 | 12.92 |
| 09:59 ET | 100 | 12.92 |
| 10:01 ET | 100 | 13.04 |
| 10:03 ET | 100 | 12.92 |
| 10:06 ET | 100 | 12.92 |
| 10:08 ET | 100 | 12.92 |
| 10:10 ET | 100 | 12.92 |
| 10:12 ET | 1500 | 12.89 |
| 10:14 ET | 758 | 13.01 |
| 10:17 ET | 1000 | 13.16 |
| 10:24 ET | 1146 | 13 |
| 10:26 ET | 397 | 13 |
| 10:30 ET | 100 | 12.96 |
| 10:32 ET | 200 | 12.98 |
| 10:33 ET | 100 | 13 |
| 10:35 ET | 947 | 12.99 |
| 10:39 ET | 100 | 13 |
| 10:42 ET | 100 | 13 |
| 10:44 ET | 100 | 12.99 |
| 10:46 ET | 300 | 13 |
| 10:50 ET | 100 | 12.99 |
| 10:51 ET | 500 | 13.095 |
| 10:55 ET | 274 | 13.06 |
| 10:57 ET | 400 | 13.025 |
| 11:00 ET | 353 | 13.08 |
| 11:02 ET | 246 | 12.995 |
| 11:09 ET | 1033 | 13 |
| 11:13 ET | 200 | 12.96 |
| 11:15 ET | 100 | 12.97 |
| 11:20 ET | 264 | 12.99 |
| 11:24 ET | 100 | 12.97 |
| 11:26 ET | 6639 | 12.98 |
| 11:29 ET | 300 | 12.96 |
| 11:31 ET | 944 | 12.96 |
| 11:33 ET | 4152 | 12.81 |
| 11:36 ET | 100 | 12.74 |
| 11:38 ET | 1000 | 12.74 |
| 11:40 ET | 1600 | 12.83 |
| 11:42 ET | 100 | 12.75 |
| 11:44 ET | 750 | 12.7 |
| 11:45 ET | 1053 | 12.69 |
| 11:49 ET | 100 | 12.65 |
| 11:51 ET | 500 | 12.69 |
| 11:54 ET | 995 | 12.705 |
| 11:56 ET | 200 | 12.73 |
| 11:58 ET | 100 | 12.72 |
| 12:02 ET | 700 | 12.72 |
| 12:03 ET | 200 | 12.72 |
| 12:05 ET | 100 | 12.67 |
| 12:09 ET | 1203 | 12.62 |
| 12:12 ET | 1334 | 12.7 |
| 12:14 ET | 700 | 12.7 |
| 12:16 ET | 200 | 12.73 |
| 12:18 ET | 500 | 12.71 |
| 12:20 ET | 400 | 12.7 |
| 12:21 ET | 200 | 12.71 |
| 12:23 ET | 100 | 12.705 |
| 12:25 ET | 1680 | 12.7 |
| 12:27 ET | 1183 | 12.665 |
| 12:30 ET | 1200 | 12.65 |
| 12:34 ET | 125 | 12.6325 |
| 12:36 ET | 200 | 12.665 |
| 12:38 ET | 600 | 12.67 |
| 12:41 ET | 400 | 12.65 |
| 12:43 ET | 500 | 12.71 |
| 12:45 ET | 6302 | 12.725 |
| 12:48 ET | 200 | 12.73 |
| 12:52 ET | 200 | 12.725 |
| 12:54 ET | 100 | 12.725 |
| 12:57 ET | 462 | 12.73 |
| 12:59 ET | 1695 | 12.79 |
| 01:03 ET | 100 | 12.75 |
| 01:08 ET | 100 | 12.75 |
| 01:14 ET | 400 | 12.75 |
| 01:15 ET | 200 | 12.72 |
| 01:17 ET | 1135 | 12.795 |
| 01:19 ET | 1032 | 12.8 |
| 01:21 ET | 200 | 12.795 |
| 01:24 ET | 200 | 12.795 |
| 01:26 ET | 100 | 12.795 |
| 01:28 ET | 300 | 12.83 |
| 01:30 ET | 100 | 12.83 |
| 01:32 ET | 1300 | 12.88 |
| 01:35 ET | 1000 | 12.78 |
| 01:37 ET | 100 | 12.81 |
| 01:39 ET | 600 | 12.755 |
| 01:42 ET | 300 | 12.71 |
| 01:44 ET | 360 | 12.77 |
| 01:46 ET | 400 | 12.73 |
| 01:48 ET | 305 | 12.77 |
| 01:50 ET | 230 | 12.78 |
| 01:51 ET | 300 | 12.76 |
| 01:53 ET | 100 | 12.76 |
| 01:55 ET | 283 | 12.775 |
| 01:57 ET | 581 | 12.79 |
| 02:00 ET | 300 | 12.8 |
| 02:02 ET | 100 | 12.77 |
| 02:08 ET | 400 | 12.76 |
| 02:11 ET | 500 | 12.76 |
| 02:13 ET | 200 | 12.76 |
| 02:15 ET | 300 | 12.78 |
| 02:18 ET | 300 | 12.76 |
| 02:20 ET | 300 | 12.76 |
| 02:22 ET | 100 | 12.77 |
| 02:24 ET | 1968 | 12.775 |
| 02:29 ET | 200 | 12.775 |
| 02:33 ET | 300 | 12.775 |
| 02:36 ET | 100 | 12.775 |
| 02:38 ET | 200 | 12.775 |
| 02:40 ET | 400 | 12.76 |
| 02:42 ET | 400 | 12.775 |
| 02:44 ET | 300 | 12.77 |
| 02:45 ET | 1487 | 12.8 |
| 02:47 ET | 325 | 12.81 |
| 02:49 ET | 1954 | 12.8 |
| 02:51 ET | 3600 | 12.785 |
| 02:54 ET | 700 | 12.84 |
| 02:56 ET | 300 | 12.82 |
| 03:02 ET | 200 | 12.81 |
| 03:03 ET | 100 | 12.81 |
| 03:05 ET | 300 | 12.81 |
| 03:07 ET | 300 | 12.81 |
| 03:09 ET | 3846 | 12.81 |
| 03:12 ET | 100 | 12.81 |
| 03:14 ET | 100 | 12.81 |
| 03:18 ET | 100 | 12.79 |
| 03:20 ET | 1718 | 12.74 |
| 03:21 ET | 500 | 12.75 |
| 03:23 ET | 100 | 12.72 |
| 03:25 ET | 3575 | 12.7 |
| 03:27 ET | 2456 | 12.75 |
| 03:30 ET | 2785 | 12.735 |
| 03:34 ET | 200 | 12.75 |
| 03:38 ET | 1100 | 12.74 |
| 03:39 ET | 468 | 12.745 |
| 03:41 ET | 300 | 12.745 |
| 03:43 ET | 100 | 12.75 |
| 03:45 ET | 5173 | 12.8 |
| 03:48 ET | 1216 | 12.81 |
| 03:50 ET | 2397 | 12.83 |
| 03:52 ET | 1765 | 12.845 |
| 03:54 ET | 1252 | 12.86 |
| 03:56 ET | 1495 | 12.885 |
| 03:57 ET | 2468 | 12.85 |
| 03:59 ET | 32092 | 12.87 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Inhibrx Biosciences Inc | 194.6M | -2.4x | --- |
Century Therapeutics Inc | 191.8M | -1.0x | --- |
Prelude Therapeutics Inc | 198.8M | -1.9x | --- |
Aldeyra Therapeutics Inc | 190.1M | -6.3x | --- |
Q32 Bio Inc | 207.0M | -0.7x | --- |
Acrivon Therapeutics Inc | 189.6M | -2.5x | --- |
Company Information
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. The Company’s clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106. INBRX-109 is a tetravalent agonist of death receptor 5 (DR5) that is designed with its proprietary single domain antibody, or sdAb, platform to drive cancer-selective programmed cell death and to maximize potency while minimizing on-target liver toxicity arising from hepatocyte apoptosis. INBRX-106 is a hexavalent OX40 agonist, being investigated as a single agent and in combination with Keytruda, a PD-1 blocking checkpoint inhibitor, in patients with locally advanced or metastatic solid tumors. INBRX-106 is a precisely engineered hexavalent sdAb-based therapeutic candidate targeting OX40, designed to be an optimized agonist of this co-stimulatory receptor.
Contact Information
- Headquarters
- 11025 N. Torrey Pines Road, Suite 140LA JOLLA, CA, United States 92037
- Phone
- 858-795-4220
- Fax
- 302-636-5454
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $194.6M |
|---|---|
Revenue (TTM) | $1.8M |
Shares Outstanding | 14.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-5.35 |
Book Value | $0.92 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | 109.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -13,980.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
